Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation / 영남의대학술지
Yeungnam University Journal of Medicine
;
: 150-154, 2016.
Article
in Korean
| WPRIM
| ID: wpr-78776
ABSTRACT
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ribavirin
/
Prevalence
/
Interferons
/
Kidney Transplantation
/
Hepacivirus
/
Hepatitis C, Chronic
/
Allografts
/
Transplant Recipients
/
Hepatitis, Chronic
/
Kidney
Type of study:
Prevalence study
Limits:
Humans
Language:
Korean
Journal:
Yeungnam University Journal of Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS